Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000108

Chief Medical Officer sold 7,000 shares at an average $74.81 ($523,648)

  • Chief Medical Officer acquired 7,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Goncalves Joana Chief Medical Officer 2026-10-15 Option exercise 10b5-1 +3,500 $6.84 $23,940 35,271 D
Goncalves Joana Chief Medical Officer 2026-10-15 Option exercise 10b5-1 +3,500 $7.80 $27,300 38,771 D
Goncalves Joana Chief Medical Officer 2026-10-15 Sale 10b5-1 −2,853 $73.89 $210,806 35,918 D
Goncalves Joana Chief Medical Officer 2026-10-15 Sale 10b5-1 −1,847 $74.69 $137,957 34,071 D
Goncalves Joana Chief Medical Officer 2026-10-15 Sale 10b5-1 −1,400 $75.48 $105,677 32,671 D
Goncalves Joana Chief Medical Officer 2026-10-15 Sale 10b5-1 −700 $76.67 $53,666 31,971 D
Goncalves Joana Chief Medical Officer 2026-10-15 Sale 10b5-1 −200 $77.71 $15,542 31,771 D
Derivatives
Goncalves Joana Chief Medical Officer 2026-10-15 Option exercise · Employee Stock Option (right to buy) 10b5-1 −3,500 190,063 D
Goncalves Joana Chief Medical Officer 2026-10-15 Option exercise · Employee Warrant (right to buy) 10b5-1 −3,500 161,492 D
Open-market sales · 7,000 sh · avg $74.81 · $523,648
Loading xslF345X06/form4.xml…